Puriss Co., Ltd.

Legal Opinion on the 2025 Annual Shareholders Meeting of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Announcement on the actual controller of the company renewing the concerted action agreement

Announcement on Applying for Credit Limit from the Bank

Announcement on the Company's Proposal to Reappoint the Accounting Firm for 2026

Huatai United Securities Co., Ltd. Continuous Supervision Tracking Report for 2025 of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Huatai United Securities Co., Ltd. Summary Report on the Sponsorship of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd. for Initial Public Offering and Listing on the Growth Enterprise Market

Independent Director Mr. Huang Huasheng's 2025 Annual Work Report

Independent Director Mr. Liu Xue's 2025 Annual Work Report

Independent Director Mr. Liao Xiansheng's 2025 Annual Work Report

Announcement on the 2025 Performance Presentation Meeting

2025 Environmental, Social, and Corporate Governance Report

Huatai United Securities Co., Ltd. Regarding the Verification Opinion on the Self-evaluation Report on Internal Control for 2025 of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Internal Control Audit Report for 2025

Self-evaluation Report on Internal Control for 2025

Shareholder Dividend Return Plan for the Next Three Years (2026-2028)

Remuneration and Assessment Management System for Directors and Senior Management (April 2026)

Announcement on the Provision for Asset Impairment and Credit Impairment for 2025

Notice of the 2025 Annual Shareholders' Meeting

Resolution Announcement of the Second Meeting of the Fourth Board of Directors

Announcement on the Profit Distribution Plan for 2025

Q1 2026 Report

Special Report on the Storage, Management, and Use of Raised Funds for 2025

Verification Report on the Special Report of Storage, Management, and Use of Raised Funds for 2025 of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Huatai United Securities Co., Ltd. Regarding the Verification Opinion on the Storage, Management, and Use of Raised Funds for 2025 of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Evaluation Report on the Performance of the Accounting Firm for 2025

Audit Committee of the Board of Directors' Report on the Accounting Firm's Performance of Supervisory Responsibilities for 2025

Special Report on Non-operating Fund Occupation and Other Related Fund Transactions for 2025 of Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd.

Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions for 2025

Board of Directors' Special Opinion on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report